Eupraxia Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.05-3.91-6.86-12.11-2.31-3.31-2.52N/A-12.11
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
7.98-4.68-2.78-2.282.605.9942.55N/A-2.28
Price/Cash Flow ratio
-9.01-6.22-9.52-119.85-3.62-4.10-3.37N/A-119.85
Price/Free Cash Flow ratio
-8.50-6.12-9.50-119.85-3.52-4.03-3.36N/A-119.85
Price/Earnings Growth ratio
N/A-0.010.150.27-0.000.13-0.08N/A0.27
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
12.55%9.83%-19.32%-46.58%5.74%-3.89%0.22%N/A-46.58%
Return on Assets
-73.90%-454.82%-218.44%-274.98%-73.63%-89.88%-139.92%N/A-274.98%
Return On Equity
-72.22%119.64%40.56%18.84%-112.76%-180.93%-1687.19%N/A18.84%
Return on Capital Employed
-97.24%125.17%35.36%10.64%-72.08%-104.14%-3135.82%N/A10.64%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
7.420.170.120.0513.496.070.77N/A0.05
Cash ratio
5.460.050.050.009.215.970.99N/A0.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A1.303.538.610.290.460.51N/A8.61
Debt Equity Ratio
N/A-0.34-0.65-0.590.450.936.21N/A-0.59
Long-term Debt to Capitalization
N/AN/AN/AN/A0.310.48N/AN/AN/A
Total Debt to Capitalization
N/A-0.52-1.91-1.440.310.480.86N/A-1.44
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A-2.19-0.44-0.03-1.56-1.55-2.02N/A-0.03
Company Equity Multiplier
0.97-0.26-0.18-0.061.532.0112.05N/A-0.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.051.011.0011.021.011.00N/A1
Cash Flow Coverage Ratio
N/A-2.19-0.44-0.03-1.56-1.55-2.02N/A-0.03
Short Term Coverage Ratio
N/A-2.19-0.44-0.03-196.68-236.42-2.02N/A-0.03
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A